UPDATE : Tuesday, August 14, 2018
상단여백
Samsung BioLogics posts $112 million in Q3 sales
Samsung BioLogics (CEO: Kim Tae-han) Wednesday posted the sales of 127.5 bi...
by Marian Chu  |  2017-10-25 17:34
라인
Rain-Kim Tae-hee couple to store umbilical cord blood of newborn daughter
Actress Kim Tae-hee and K-pop star and actor Rain hold a wedding in January...
by Marian Chu  |  2017-10-25 16:45
라인
2017 Bio Future Forum analyzes coming of bio-economy era
The 2017 Bio Future Forum opened its third annual conference to discuss the...
by Lee Han-soo  |  2017-10-25 15:43
라인
Toolgen, Rebelbio agree to help bio ventures
Toolgen said Monday that it has agreed to cooperate with Rebelbio, a seed b...
by Lee Han-soo  |  2017-10-23 16:19
라인
‘2017 Korea Bioplus’ diagnoses global biotechnology issues
The 2017 Korea Bioplus opened its third annual conference to discuss global...
by Lee Han-soo  |  2017-10-23 14:38
라인
Celltrion stock’s short sale causes controversy over trading rules
Stock investors short sold Celltrion stocks worth 50.5 billion won ($44.5 m...
by Lee Han-soo  |  2017-10-19 18:49
라인
ViroMed eyes global market entry with ‘revolutionary’ gene therapy
ViroMed is making more progress with its gene therapy, having registered th...
by Marian Chu  |  2017-10-19 17:28
라인
Will induced pluripotent stem cells avoid ethical issues?
Stem cell researchers and related industry officials are paying attention t...
by Nam Doo-hyun  |  2017-10-17 15:25
라인
TissueGene promotes cell gene therapy Invossa ahead of IPO
TissueGene, the U.S.-based biopharmaceutical firm held mostly by Korea’s Ko...
by Lee Hye-seon  |  2017-10-17 14:32
라인
Gemvax&Kael present clinical results of prostatic hyperplasia treatment
Gemvax&Kael released its phase-2 domestic clinical trial results of GV1001,...
by Lee Han-soo  |  2017-10-16 16:09
라인
Stem cell treatment for diabetes nears
Korean diabetes patients might have come one step closer to getting a stem ...
by Nam Doo-hyun  |  2017-10-13 15:47
라인
Samsung BioLogics’ 2nd factory gets FDA approval
Samsung BioLogics said Thursday that its second factory received manufactur...
by Lee Han-soo  |  2017-10-12 15:31
라인
Celltrion rises high in Korean stock market
South Korean biopharmaceutical firm Celltrion’s shares rose high in the loc...
by Nam Doo-hyun  |  2017-10-11 16:11
라인
Samsung Bioepis teams up with Yuhan for biosimilars
Samsung Bioepis, which recently terminated its biosimilar sales deal with t...
by Lee Hye-seon  |  2017-10-11 14:25
라인
Patents on cancer biomarker kit increase at fast pace
Patents related to cancer biomarker kit, also known as an in-vitro diagnost...
by Lee Han-soo  |  2017-10-10 17:44
라인
CJ Healthcare, YL Biologics signs technology transfer agreement
CJ Healthcare said Thursday that it has signed an agreement with YL Biologi...
by Lee Han-soo  |  2017-09-28 15:01
라인
LegoChem, Geom Therapeutics signs technology transfer accord
LegoChem Bioscience said Wednesday that it has signed an agreement with Geo...
by Lee Han-soo  |  2017-09-27 17:52
라인
Aprogen’s rheumatoid arthritis biosimilar wins sales approval in Japan
Aprogen Pharmaceuticals said Wednesday that the company’s NI-071 (Original:...
by Lee Han-soo  |  2017-09-27 17:45
라인
Celltrion will use Oracle Health platform to streamline processes
Celltrion will use Oracle Health platforms to help streamline regulatory re...
by Marian Chu  |  2017-09-27 10:47
라인
Can Celltrion, Samsung make stable earnings with biosimilar?
Amid the intensifying competition to lower drug prices, market watchers pre...
by Nam Doo-hyun  |  2017-09-26 17:31
여백
여백
여백
Back to Top